Nintedanib - Latest Advances

Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Published: December 16, 2025

Nerandomilast (Jascayd) for idiopathic pulmonary fibrosis.

Journal: The Medical letter on drugs and therapeutics

Published: December 15, 2025

A novel homozygous HPS4 mutation in Hermansky-Pudlak syndrome: case report and literature review.

Journal: Therapeutic advances in respiratory disease

Published: November 24, 2025

Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis.

Journal: Cancer biology & medicine

Published: November 19, 2025

Characterisation of patients with antifibrotic-treated non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis: a retrospective real-life study.

Journal: BMJ open

Published: November 17, 2025

Erratum to: Nintedanib Inhibits VEGF-Induced Neovascularization in Human Conjunctival Vascular Endothelial Cells.

Journal: Current medical science

Published: November 07, 2025

Nifedipine and mycophenolate mofetil-induced gingival hyperplasia in a patient with systemic sclerosis: Role of concomitant therapy and pharmacovigilance aspects.

Journal: The International journal of risk & safety in medicine

Published: November 05, 2025

First Report of Trametinib-Nintedanib Combination in KRAS G12D-Mutated Pancreatic Cancer: Efficacy and Fatal Hemorrhagic Complication: A Case Report.

Journal: Clinical case reports

Published: October 13, 2025

Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study.

Journal: Journal of clinical medicine

Published: October 12, 2025

Response to Letter to the Editor: Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis From a Multicenter Observational Study in Kyushu and Okinawa, Japan.

Journal: Clinical therapeutics

Published: October 09, 2025

Vascular endothelial cells and angiogenesis.

Journal: Pharmacological research

Published: October 04, 2025

Tweaking the complex fibrogenic role of lymphocytes in IPF.

Journal: Tuberculosis and respiratory diseases

Published: September 29, 2025

Filters

Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease

Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease

Nerandomilast (Jascayd) for idiopathic pulmonary fibrosis.

Nerandomilast (Jascayd) for idiopathic pulmonary fibrosis.

A novel homozygous HPS4 mutation in Hermansky-Pudlak syndrome: case report and literature review.

A novel homozygous HPS4 mutation in Hermansky-Pudlak syndrome: case report and literature review.

Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis.

Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis.

Characterisation of patients with antifibrotic-treated non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis: a retrospective real-life study.

Characterisation of patients with antifibrotic-treated non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis: a retrospective real-life study.

Erratum to: Nintedanib Inhibits VEGF-Induced Neovascularization in Human Conjunctival Vascular Endothelial Cells.

Erratum to: Nintedanib Inhibits VEGF-Induced Neovascularization in Human Conjunctival Vascular Endothelial Cells.

Nifedipine and mycophenolate mofetil-induced gingival hyperplasia in a patient with systemic sclerosis: Role of concomitant therapy and pharmacovigilance aspects.

Nifedipine and mycophenolate mofetil-induced gingival hyperplasia in a patient with systemic sclerosis: Role of concomitant therapy and pharmacovigilance aspects.

First Report of Trametinib-Nintedanib Combination in KRAS G12D-Mutated Pancreatic Cancer: Efficacy and Fatal Hemorrhagic Complication: A Case Report.

First Report of Trametinib-Nintedanib Combination in KRAS G12D-Mutated Pancreatic Cancer: Efficacy and Fatal Hemorrhagic Complication: A Case Report.

Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study.

Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study.

Response to Letter to the Editor: Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis From a Multicenter Observational Study in Kyushu and Okinawa, Japan.

Response to Letter to the Editor: Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis From a Multicenter Observational Study in Kyushu and Okinawa, Japan.

Vascular endothelial cells and angiogenesis.

Vascular endothelial cells and angiogenesis.

Tweaking the complex fibrogenic role of lymphocytes in IPF.

Tweaking the complex fibrogenic role of lymphocytes in IPF.